This DARPA grant, In vivo Nanoplatforms for Diagnostics (IVN:Dx), is for developing biocompatible nanosensors. The objective is to achieve continuous, noninvasive, and highly accurate measurement of various conditions and substances directly within living tissues of animals, plants, and insects. These sensors, made from non-toxic materials with limited immunogenicity, will enable qualitative and quantitative assessment over large concentration ranges. They will target both small molecules (e.g., glucose, lactate) and large molecules (e.g., proteins, infectious agents, threat agents). Detection will occur via optical, electronic, thermal, or magnetic mechanisms, providing versatile diagnostic capabilities.
Opportunity ID: 153455
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | DARPA-BAA-12-33 |
| Funding Opportunity Title: | In vivo Nanoplatforms for Diagnostics (IVN:Dx) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 12.910 — Research and Technology Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 15, 2012 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jun 28, 2012 |
| Current Closing Date for Applications: | Jun 28, 2012 |
| Archive Date: | Dec 28, 2012 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | DARPA – Microsystems Technology Office |
| Description: | The specific objective of the In vivo Nanoplatforms for Diagnostics (IVN:Dx) thrust of the In vivo Nanoplatforms (IVN) program is to develop biocompatible nanosensors that provide continuous, noninvasive, and highly accurate measurement of a variety of conditions and substances within the living tissue of animals, plants, and insects using non-toxic materials with limited immunogenicity. These sensors will permit qualitative and quantitative assessment over large concentration ranges of both small (e.g., glucose, lactate, and urea) and large molecules (e.g., proteins, oligonucleotides, infectious agents, and chemical/biological threat agents) in the organism and environment through optical, electronic, thermal or magnetic mechanisms.
See full DARPA-BAA-12-33 attached. |
| Link to Additional Information: | MTO Solicitations Page |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Dr. Timothy Broderick
Program Manager Email:DARPA-BAA-12-33@darpa.mil |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 153455 Full Announcement-1 -> approved proposer checklist.pdf
Folder 153455 Full Announcement-1 -> darpa-baa-12-33_ivn dx_final for posting_15march12.pdf
Packages
| Agency Contact Information: | Dr. Timothy Broderick Program Manager Email: DARPA-BAA-12-33@darpa.mil |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.910 | PKG00105990 | Mar 15, 2012 | Jun 28, 2012 | View |
Package 1
Mandatory forms
153455 RR_SF424_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
